false
--12-31
2026
Q1
0000736012
1
1366
3563
2098
0000736012
2026-01-01
2026-03-31
0000736012
2026-05-14
0000736012
2026-03-31
0000736012
2025-12-31
0000736012
2025-01-01
2025-03-31
0000736012
intz:SeriesAPreferredStocksMember
2025-12-31
0000736012
us-gaap:CommonStockMember
2025-12-31
0000736012
us-gaap:TreasuryStockCommonMember
2025-12-31
0000736012
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-12-31
0000736012
us-gaap:AdditionalPaidInCapitalMember
2025-12-31
0000736012
intz:StockSubscriptionReceivbleMember
2025-12-31
0000736012
us-gaap:RetainedEarningsMember
2025-12-31
0000736012
intz:SeriesAPreferredStocksMember
2024-12-31
0000736012
us-gaap:CommonStockMember
2024-12-31
0000736012
us-gaap:TreasuryStockCommonMember
2024-12-31
0000736012
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-12-31
0000736012
us-gaap:AdditionalPaidInCapitalMember
2024-12-31
0000736012
intz:StockSubscriptionReceivbleMember
2024-12-31
0000736012
us-gaap:RetainedEarningsMember
2024-12-31
0000736012
2024-12-31
0000736012
intz:SeriesAPreferredStocksMember
2026-01-01
2026-03-31
0000736012
us-gaap:CommonStockMember
2026-01-01
2026-03-31
0000736012
us-gaap:TreasuryStockCommonMember
2026-01-01
2026-03-31
0000736012
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-01-01
2026-03-31
0000736012
us-gaap:AdditionalPaidInCapitalMember
2026-01-01
2026-03-31
0000736012
intz:StockSubscriptionReceivbleMember
2026-01-01
2026-03-31
0000736012
us-gaap:RetainedEarningsMember
2026-01-01
2026-03-31
0000736012
intz:SeriesAPreferredStocksMember
2025-01-01
2025-03-31
0000736012
us-gaap:CommonStockMember
2025-01-01
2025-03-31
0000736012
us-gaap:TreasuryStockCommonMember
2025-01-01
2025-03-31
0000736012
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-01-01
2025-03-31
0000736012
us-gaap:AdditionalPaidInCapitalMember
2025-01-01
2025-03-31
0000736012
intz:StockSubscriptionReceivbleMember
2025-01-01
2025-03-31
0000736012
us-gaap:RetainedEarningsMember
2025-01-01
2025-03-31
0000736012
intz:SeriesAPreferredStocksMember
2026-03-31
0000736012
us-gaap:CommonStockMember
2026-03-31
0000736012
us-gaap:TreasuryStockCommonMember
2026-03-31
0000736012
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-03-31
0000736012
us-gaap:AdditionalPaidInCapitalMember
2026-03-31
0000736012
intz:StockSubscriptionReceivbleMember
2026-03-31
0000736012
us-gaap:RetainedEarningsMember
2026-03-31
0000736012
intz:SeriesAPreferredStocksMember
2025-03-31
0000736012
us-gaap:CommonStockMember
2025-03-31
0000736012
us-gaap:TreasuryStockCommonMember
2025-03-31
0000736012
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-03-31
0000736012
us-gaap:AdditionalPaidInCapitalMember
2025-03-31
0000736012
intz:StockSubscriptionReceivbleMember
2025-03-31
0000736012
us-gaap:RetainedEarningsMember
2025-03-31
0000736012
2025-03-31
0000736012
2026-04-05
2026-04-06
0000736012
intz:OperatingRouLeasesMember
2026-03-31
0000736012
intz:FinanceRouLeasesMember
2026-03-31
0000736012
intz:StreetervilleCapitalMember
2022-03-10
0000736012
intz:StreetervilleDebtMember
us-gaap:CommonStockMember
2024-01-01
2024-12-31
0000736012
intz:StreetervilleDebtMember
2025-01-01
2025-03-31
0000736012
intz:StreetervilleMember
intz:StandbyEquityPurchaseAgreementMember
2024-07-03
0000736012
intz:StreetervilleMember
intz:StandbyEquityPurchaseAgreementMember
2024-01-01
2024-12-31
0000736012
intz:StreetervilleMember
intz:StandbyEquityPurchaseAgreementMember
2024-01-01
2025-12-31
0000736012
intz:StreetervilleMember
intz:StandbyEquityPurchaseAgreementMember
intz:ReceivedIn2024Member
2024-01-01
2024-12-31
0000736012
intz:StreetervilleMember
intz:StandbyEquityPurchaseAgreementMember
2025-01-01
2025-03-31
0000736012
us-gaap:SeriesAPreferredStockMember
2024-03-15
0000736012
intz:StreetervilleCapitalMember
intz:ExchangeAgreementMember
2024-03-14
2024-03-15
0000736012
intz:StreetervilleCapitalMember
intz:ExchangeAgreementMember
us-gaap:SeriesAPreferredStockMember
2024-03-14
2024-03-15
0000736012
us-gaap:SeriesAPreferredStockMember
2024-12-31
0000736012
us-gaap:SeriesAPreferredStockMember
intz:Section3a9Member
2025-01-01
2025-01-31
0000736012
us-gaap:CommonStockMember
intz:Section3a9Member
2025-01-01
2025-01-31
0000736012
us-gaap:SeriesAPreferredStockMember
intz:SEPAAgreementMember
2025-01-01
2025-01-31
0000736012
intz:RegisteredDirectOfferingMember
us-gaap:CommonStockMember
2025-01-05
2025-01-06
0000736012
intz:RegisteredDirectOfferingMember
intz:PreFundedWarrantsMember
2025-01-05
2025-01-06
0000736012
intz:RegisteredDirectOfferingMember
2025-01-05
2025-01-06
0000736012
intz:CommonStockWarrantsMember
2026-03-31
0000736012
intz:CommonStockWarrantsMember
2026-01-01
2026-03-31
0000736012
us-gaap:RestrictedStockUnitsRSUMember
2026-01-01
2026-03-31
0000736012
us-gaap:RestrictedStockUnitsRSUMember
2025-01-01
2025-03-31
0000736012
intz:ThreeGovernmentCustomersMember
2026-01-01
2026-03-31
0000736012
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
intz:ThreeGovernmentCustomersMember
2026-01-01
2026-03-31
0000736012
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
intz:TopCustomer1Member
2026-01-01
2026-03-31
0000736012
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
intz:TopCustomer2Member
2026-01-01
2026-03-31
0000736012
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
intz:TopCustomer3Member
2026-01-01
2026-03-31
0000736012
intz:FourGovernmentCustomersMember
2025-01-01
2025-03-31
0000736012
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
intz:FourGovernmentCustomersMember
2025-01-01
2025-03-31
0000736012
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
intz:TopCustomer1Member
2025-01-01
2025-03-31
0000736012
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
intz:TopCustomer2Member
2025-01-01
2025-03-31
0000736012
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
intz:TopCustomer3Member
2025-01-01
2025-03-31
0000736012
2025-01-01
2025-12-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
intz:Integer
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
| ☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| |
| For the quarterly period ended March 31, 2026 |
| |
| OR |
| |
| ☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| |
| For the transition period from to |
| |
| Commission File Number 001-39608 |
INTRUSION INC.
(Exact name of registrant as specified in its charter)
| Delaware |
75-1911917 |
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
101 East Park Blvd, Suite 1200, Plano, Texas
75074
(Address of principal executive offices)
(Zip Code)
(888) 637-7770
(Registrant’s telephone number, including
area code)
N/A
(Former name, former address and former fiscal
year, if changed since last report)
* * * * * * * * * *
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
| Common Stock, par value $0.01 per share |
INTZ |
Nasdaq Capital Market |
Indicate by check mark whether the Registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days.
Yes ☒ No
☐
Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes ☒ No
☐
Indicate by check mark whether the
registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth
company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large, accelerated filer |
☐ |
|
Accelerated filer |
☐ |
| Non-accelerated filer |
☒ |
|
Smaller reporting company |
☒ |
| |
|
|
Emerging growth company |
☐ |
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the Registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☐ No ☒
The number of shares outstanding of the Registrant’s
Common Stock, $0.01 par value, on May 14, 2026, was 20,369,066.
INTRUSION INC.
INDEX
| PART I – FINANCIAL INFORMATION |
3 |
| |
|
| Item 1. Financial Statements |
3 |
| |
|
| Condensed Consolidated Balance
Sheets as of March 31, 2026 (unaudited), and December 31, 2025 |
3 |
| |
|
| Unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2026, and 2025 |
4 |
| |
|
| Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three months ended March 31, 2026, and 2025 |
5 |
| |
|
| Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2026, and 2025 |
6 |
| |
|
| Notes to Unaudited Condensed Consolidated Financial Statements |
7 |
| |
|
| Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations |
15 |
| |
|
| Item 3. Quantitative and Qualitative Disclosures About Market Risk |
19 |
| |
|
| Item 4. Controls and Procedures |
19 |
| |
|
| PART II – OTHER INFORMATION |
20 |
| |
|
| Item 1. Legal Proceedings |
20 |
| |
|
| Item 1A. Risk Factors |
20 |
| |
|
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds and Issuer Purchases of Equity Securities |
20 |
| |
|
| Item 3. Defaults Upon Senior Securities |
20 |
| |
|
| Item 4. Mine Safety Disclosures |
20 |
| |
|
| Item 5. Other Information |
20 |
| |
|
| Item 6. Exhibits |
21 |
| |
|
| Signature Page |
22 |
PART I – FINANCIAL INFORMATION
Item 1. FINANCIAL STATEMENTS
INTRUSION INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except par value amounts)
| | |
| | |
| |
| | |
March 31, 2026 | | |
December 31, 2025 | |
| | |
(unaudited) | | |
| |
| ASSETS | |
| | | |
| | |
| Current Assets: | |
| | | |
| | |
| Cash and cash equivalents | |
$ | 1,366 | | |
$ | 3,624 | |
| Accounts receivable, net of allowance of $0.1 million | |
| 37 | | |
| 131 | |
| Prepaid expenses and other assets | |
| 602 | | |
| 476 | |
| Total current assets | |
| 2,005 | | |
| 4,231 | |
| Noncurrent Assets: | |
| | | |
| | |
| Property and equipment: | |
| | | |
| | |
| Equipment | |
| 2,971 | | |
| 2,917 | |
| Capitalized software development | |
| 5,861 | | |
| 5,663 | |
| Leasehold improvements | |
| 18 | | |
| 18 | |
| Property and equipment, gross | |
| 8,850 | | |
| 8,598 | |
| Accumulated depreciation and amortization | |
| (4,687 | ) | |
| (4,313 | ) |
| Property and equipment, net | |
| 4,163 | | |
| 4,285 | |
| Finance leases, right-of-use assets (“ROU”),
net | |
| 193 | | |
| 222 | |
| Operating leases, ROU, net | |
| 1,320 | | |
| 1,392 | |
| Other assets | |
| 256 | | |
| 257 | |
| Total noncurrent assets | |
| 5,932 | | |
| 6,156 | |
| TOTAL ASSETS | |
$ | 7,937 | | |
$ | 10,387 | |
| | |
| | | |
| | |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |
| | | |
| | |
| Current Liabilities: | |
| | | |
| | |
| Accounts payable, trade | |
$ | 1,049 | | |
$ | 492 | |
| Accrued expenses | |
| 519 | | |
| 357 | |
| Finance lease liabilities, current portion | |
| 127 | | |
| 167 | |
| Operating leases liabilities, current portion | |
| 146 | | |
| 266 | |
| Deferred revenue | |
| 1,044 | | |
| 503 | |
| Total current liabilities | |
| 2,885 | | |
| 1,785 | |
| | |
| | | |
| | |
| Noncurrent Liabilities: | |
| | | |
| | |
| Finance lease liabilities, noncurrent portion | |
| 5 | | |
| 6 | |
| Operating lease liabilities, noncurrent portion | |
| 1,348 | | |
| 1,319 | |
| Total noncurrent liabilities | |
| 1,353 | | |
| 1,325 | |
| | |
| | | |
| | |
| Commitments and Contingencies – (See Note 5) | |
| – | | |
| – | |
| | |
| | | |
| | |
| Stockholders’ Equity: | |
| | | |
| | |
| Preferred stock, $0.01 par value: Authorized shares – 5,000;
Issued shares – 0 in 2026 and 2025 | |
| – | | |
| – | |
| Common stock, $0.01
par value: Authorized shares – 80,000;
Issued shares – 20,370
in 2026 and 20,117
in 2025; Outstanding shares – 20,369
in 2026 and 20,116
in 2025 | |
| 204 | | |
| 201 | |
| Common stock held in treasury, at cost – 1 share(s) | |
| (362 | ) | |
| (362 | ) |
| Additional paid-in capital | |
| 134,529 | | |
| 134,547 | |
| Accumulated deficit | |
| (130,629 | ) | |
| (127,066 | ) |
| Accumulated other comprehensive loss | |
| (43 | ) | |
| (43 | ) |
| Total stockholders’ equity | |
| 3,699 | | |
| 7,277 | |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | |
$ | 7,937 | | |
$ | 10,387 | |
The accompanying notes are an integral part of
these unaudited condensed consolidated financial statements.
INTRUSION INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
| | |
| | |
| |
| | |
Three Months Ended March 31, | |
| | |
2026 | | |
2025 | |
| Revenue | |
$ | 888 | | |
$ | 1,775 | |
| Cost of revenue | |
| 229 | | |
| 432 | |
| | |
| | | |
| | |
| Gross profit | |
| 659 | | |
| 1,343 | |
| | |
| | | |
| | |
| Operating expenses: | |
| | | |
| | |
| Sales and marketing | |
| 1,631 | | |
| 1,184 | |
| Research and development | |
| 1,451 | | |
| 1,218 | |
| General and administrative | |
| 1,149 | | |
| 1,034 | |
| | |
| | | |
| | |
| Operating loss | |
| (3,572 | ) | |
| (2,093 | ) |
| | |
| | | |
| | |
| Interest expense | |
| (11 | ) | |
| (29 | ) |
| Other income (expense), net | |
| 20 | | |
| 24 | |
| | |
| | | |
| | |
| Net loss | |
$ | (3,563 | ) | |
$ | (2,098 | ) |
| | |
| | | |
| | |
| Net loss per share: | |
| | | |
| | |
| Basic | |
$ | (0.18 | ) | |
$ | (0.11 | ) |
| Diluted | |
$ | (0.18 | ) | |
$ | (0.11 | ) |
| | |
| | | |
| | |
| Weighted average common shares outstanding: | |
| | | |
| | |
| Basic | |
| 20,274 | | |
| 19,216 | |
| Diluted | |
| 20,274 | | |
| 19,216 | |
The accompanying notes are an integral part of
these unaudited condensed consolidated financial statements.
INTRUSION INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF
CHANGES IN STOCKHOLDERS’ EQUITY
(In thousands)
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| | |
Series A Preferred Stock | | |
Common Stock | | |
Treasury Stock | | |
Accumulated Other Comprehensive | | |
Additional Paid-In | | |
Stock Subscription | | |
Accumulated | | |
| |
| | |
Dollars | | |
Shares | | |
Dollars | | |
Shares | | |
Dollars | | |
Shares | | |
Loss | | |
Capital | | |
Receivable | | |
Deficit | | |
Total | |
| Balance, December 31, 2025 | |
$ | – | | |
| – | | |
$ | 201 | | |
| 20,117 | | |
$ | (362 | ) | |
| 1 | | |
$ | (43 | ) | |
$ | 134,547 | | |
$ | – | | |
$ | (127,066 | ) | |
$ | 7,277 | |
| Stock-based compensation expense | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| 129 | | |
| – | | |
| – | | |
| 129 | |
| At-the-market (“ATM”) offering fees | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| (3 | ) | |
| – | | |
| – | | |
| (3 | ) |
| Restricted stock units
vested, net of tax withholding | |
| – | | |
| – | | |
| 3 | | |
| 253 | | |
| – | | |
| – | | |
| – | | |
| (144 | ) | |
| – | | |
| – | | |
| (141 | ) |
| Net loss | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| (3,563 | ) | |
| (3,563 | ) |
| Balance, March 31, 2026 | |
$ | – | | |
| – | | |
$ | 204 | | |
| 20,370 | | |
$ | (362 | ) | |
| 1 | | |
$ | (43 | ) | |
$ | 134,529 | | |
$ | – | | |
$ | (130,629 | ) | |
$ | 3,699 | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| | |
Series A Preferred Stock | | |
Common Stock | | |
Treasury Stock | | |
Accumulated Other Comprehensive | | |
Additional Paid-In | | |
Stock Subscription | | |
Accumulated | | |
| |
| | |
Dollars | | |
Shares | | |
Dollars | | |
Shares | | |
Dollars | | |
Shares | | |
Loss | | |
Capital | | |
Receivable | | |
Deficit | | |
Total | |
| Balance, December 31, 2024 | |
$ | 3,827 | | |
| 4 | | |
$ | 156 | | |
| 15,591 | | |
$ | (362 | ) | |
| 1 | | |
$ | (43 | ) | |
$ | 122,552 | | |
$ | (1,872 | ) | |
$ | (118,007 | ) | |
$ | 6,251 | |
| Stock-based compensation expense | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| 222 | | |
| – | | |
| – | | |
| 222 | |
| Registered direct offering, net of fees | |
| – | | |
| – | | |
| 24 | | |
| 2,459 | | |
| – | | |
| – | | |
| – | | |
| 7,002 | | |
| – | | |
| – | | |
| 7,026 | |
| Issuance of common stock to reduce note payable | |
| – | | |
| – | | |
| 6 | | |
| 553 | | |
| – | | |
| – | | |
| – | | |
| 531 | | |
| – | | |
| – | | |
| 537 | |
| Exchange of Series A preferred stock for common stock | |
| (3,946 | ) | |
| (4 | ) | |
| 13 | | |
| 1,293 | | |
| – | | |
| – | | |
| – | | |
| 3,933 | | |
| – | | |
| – | | |
| – | |
| Redemption of preferred stock | |
| (187 | ) | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| | | |
| (187 | ) |
| Issuance of preferred stock for payment of preferred return | |
| 2 | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| (2 | ) | |
| – | | |
| – | | |
| – | |
| Amortization of preferred stock exchange premium | |
| 304 | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| (304 | ) | |
| – | | |
| – | | |
| – | |
| ATM offering fees | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| (79 | ) | |
| – | | |
| – | | |
| (79 | ) |
| Standby purchase agreement proceeds, net of fees | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| (143 | ) | |
| 1,872 | | |
| – | | |
| 1,729 | |
| Net loss | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| (2,098 | ) | |
| (2,098 | ) |
| Balance, March 31, 2025 | |
$ | – | | |
| – | | |
$ | 199 | | |
| 19,896 | | |
$ | (362 | ) | |
| 1 | | |
$ | (43 | ) | |
$ | 133,712 | | |
$ | – | | |
$ | (120,105 | ) | |
$ | 13,401 | |
The accompanying notes are an integral part of
these unaudited condensed consolidated financial statements.
INTRUSION INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
| | |
| | |
| |
| | |
Three Months Ended March 31, | |
| | |
2026 | | |
2025 | |
| Operating Activities: | |
| | | |
| | |
| Net loss | |
$ | (3,563 | ) | |
$ | (2,098 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| | | |
| | |
| Depreciation and amortization | |
| 405 | | |
| 540 | |
| Provision for credit losses | |
| 3 | | |
| – | |
| Stock-based compensation | |
| 129 | | |
| 222 | |
| Non-cash lease costs | |
| 104 | | |
| 11 | |
| Other non-cash interest | |
| – | | |
| 8 | |
| Changes in operating assets and liabilities: | |
| | | |
| | |
| Accounts receivable | |
| 91 | | |
| 39 | |
| Prepaid expenses and other assets | |
| (127 | ) | |
| (688 | ) |
| Accounts payable and accrued expenses | |
| 719 | | |
| 215 | |
| Operating lease liabilities | |
| (123 | ) | |
| (127 | ) |
| Deferred revenue | |
| 541 | | |
| 188 | |
| Net cash used in operating activities | |
| (1,821 | ) | |
| (1,690 | ) |
| | |
| | | |
| | |
| Investing Activities: | |
| | | |
| | |
| Purchases of property and equipment | |
| (54 | ) | |
| (392 | ) |
| Capitalized software development | |
| (198 | ) | |
| (395 | ) |
| Net cash used in investing activities | |
| (252 | ) | |
| (787 | ) |
| | |
| | | |
| | |
| Financing Activities: | |
| | | |
| | |
| Proceeds from public stock offering net of fees | |
| (3 | ) | |
| (79 | ) |
| Proceeds from registered direct offering, net of fees | |
| – | | |
| 7,026 | |
| Proceeds from stock subscription receivable | |
| – | | |
| 1,542 | |
| Reduction of finance lease liabilities | |
| (41 | ) | |
| (119 | ) |
| Cash paid for taxes withheld on net settled restricted stock unit vesting | |
| (141 | ) | |
| – | |
| Net cash (used in) provided by financing
activities | |
| (185 | ) | |
| 8,370 | |
| | |
| | | |
| | |
| Net (decrease) increase in cash and cash
equivalents | |
| (2,258 | ) | |
| 5,893 | |
| Cash and cash equivalents at beginning of period | |
| 3,624 | | |
| 4,851 | |
| Cash and cash equivalents at end of period | |
$ | 1,366 | | |
$ | 10,744 | |
| | |
| | | |
| | |
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW ACTIVITIES: | |
| | | |
| | |
| Cash paid for interest | |
$ | – | | |
$ | 3 | |
| | |
| | | |
| | |
| SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | |
| | | |
| | |
| Capitalized asset and capitalized software included in accounts payable | |
$ | – | | |
$ | 337 | |
| Common stock issued to reduce notes payable | |
$ | – | | |
$ | 537 | |
| Preferred return on preferred stock | |
$ | – | | |
$ | 2 | |
| Exchanges of preferred stock for common stock | |
$ | – | | |
$ | 3,946 | |
| Amortization of preferred stock exchange premium | |
$ | – | | |
$ | 304 | |
The accompanying notes are an integral part of
these unaudited condensed consolidated financial statements.
INTRUSION INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS
| 1. |
Description of Business |
Intrusion Inc. (together
with its consolidated subsidiaries, the “Company,” “Intrusion,” “Intrusion Inc.,” “we,”
“us,” “our,” or similar terms) was organized in Texas in September 1983 and reincorporated in Delaware in October
1995. Our principal executive offices are located at 101 East Park Boulevard, Suite 1200, Plano, Texas 75074, and our telephone number
is (888) 637-7770. Our website URL is www.intrusion.com.
The Company develops, sells,
and supports products that protect any-sized company or government organization by fusing advanced threat intelligence with real-time
mitigation to kill cyberattacks as they occur – including Zero-Days. The Company markets and distributes the Company’s solutions
through value-added resellers, managed service providers and a direct sales force. The Company’s end-user customers include United
States (“U.S.”) federal government entities, state and local government entities, and companies ranging in size from mid-market
to large enterprises.
TraceCop (“TraceCop™”)
and Savant (“Savant™”) are registered trademarks of Intrusion Inc. The Company has applied
for trademark protection for the Company’s new INTRUSION Shield cybersecurity solution.
The accompanying unaudited
condensed consolidated financial statements of the Company have been prepared in accordance with Generally Accepted Accounting Principles
in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Item
10-01 of Regulation S-X. Accordingly, they do not include all the information and disclosures required by GAAP for complete financial
statements. All adjustments that, in the opinion of management, are necessary for a fair presentation of the results of operations for
the interim periods have been made and are of a recurring nature unless otherwise disclosed herein. The results of operations for such
interim periods are not necessarily indicative of the results of operations for a full year. These unaudited condensed consolidated financial
statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report
on Form 10-K for the year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the “SEC”) on March
25, 2026 (the “2025 Annual Report”). All significant intercompany balances and transactions have been eliminated in consolidation.
The Company calculates the
fair value of its assets and liabilities which qualify as financial instruments and includes this additional information in the notes
to unaudited condensed consolidated financial statements when the fair value is different from the carrying value of these financial
instruments. The estimated fair value of accounts receivable, accounts payable and accrued expenses approximate their carrying amounts
due to the relatively short maturity of these instruments. Notes payable and financing and operating leases approximate fair value as
they bear market rates of interest. None of these instruments are held for trading purposes.
The Company’s similar product and service offerings are not viewed as individual segments, as the Company’s management analyzes
the business as a whole and expenses are not allocated to each product offering. The Company’s CEO is the Chief Operating Decision
Maker (“CODM”). The CODM utilizes both Operating Loss and Net Loss from the Consolidated Statement of Operations to assess
performance of the single segment. There are no other significant segment expenses or other segment items that would require disclosure.
As of March 31, 2026, we had
cash and cash equivalents totaling $1.4 million. On April 6, 2026, we received $3.0 million in cash related to the sale of a promissory
note. We generated a net loss of $3.6 million and $2.1 million for the three months ended March 31, 2026, and 2025, respectively.
The accompanying financial
statements have been prepared assuming that the entity will continue as a going concern. The Company continues to incur losses from operations,
negative cash flows from operations, as well as having a continued dependence on equity and debt financing. These conditions raise substantial
doubt about the Company’s ability to continue as a going concern within one year after the date of these financial statements. The
Company plans to finance operations by raising additional funds through public or private financings, including the utilization of the
ATM program. The Company can provide no assurances that additional funds will be raised or that the terms of those financings, if available
at all, will be on favorable terms or will not result in dilution to stockholders. If the Company is not able to obtain additional debt
or equity financing, the Company may be unable to implement the Company’s business plan, fund its liquidity needs, or even continue
operations. The financial statements do not include any adjustments relating to recoverability and classifications of assets and liabilities
that may be necessary if the Company is unable to continue as a going concern.
| 3. |
ROU Assets and Leasing Liabilities |
The Company has operating
and finance leases where it records the ROU assets, and a related lease liability as required under the Financial Accounting Standard
Board’s (“FASB”) Accounting Standards Codification (“ASC”) 842. The lease liabilities are determined by
the net present value of total lease payments and amortized over the life of the lease. The Company’s leases are for the following
types of assets:
| |
· |
Computer hardware and copy
machines- The Company’s finance lease ROU assets consist of computer hardware and copy machines. These leases have two and
three year lives and are in various stages of completion. |
| |
|
|
| |
· |
Office space - The Company’s operating lease ROU assets include its rental agreements for its offices in Plano, Texas, and a data service center in Allen, Texas. The Plano offices operating lease expires on April 30, 2035. The data service center operating lease expires in October 2026. |
In accordance with ASC 842,
the Company has elected practical expedients to combine lease and non-lease components, which consist principally of common area maintenance
charges, for all classes of underlying assets and to exclude leases with an initial term of 12 months or less.
As the implicit rate is not
readily determinable for the Company’s lease agreements, the Company uses an estimated incremental borrowing rate to determine the initial
present value of lease payments.
For the three months ended
March 31, 2026 and 2025, the Company had $0.1
million and $0.1 million, respectively,
in lease payments related to operating leases and had $41
thousand and $0.1 million, respectively,
in lease payments related to financing leases.
Schedule of Items Appearing on the Unaudited Condensed Consolidated
Statements of Operations (in thousands):
| Schedule of lease cost | |
| | |
| |
| | |
Three Months Ended | |
| | |
March 31, 2026 | | |
March 31, 2025 | |
| Operating expense: | |
| | | |
| | |
| Amortization Expense – Finance ROU | |
$ | 29 | | |
$ | 172 | |
| Lease expense – Operating ROU | |
| 104 | | |
| 11 | |
| Other expense: | |
| | | |
| | |
| Interest Expense – Finance ROU | |
| 12 | | |
| 20 | |
| Total Lease Expense | |
$ | 145 | | |
$ | 203 | |
Future minimum lease obligations consisted of the following as of
March 31, 2026 (in thousands):
| Schedule of future minimum lease obligations | |
| | |
| | |
| |
| | |
Operating | | |
Finance | | |
| |
| Year ending December 31, | |
ROU Leases | | |
ROU Leases | | |
Total | |
| Remaining 2026 | |
$ | 264 | | |
$ | 148 | | |
$ | 412 | |
| 2027 | |
| 146 | | |
| 4 | | |
| 150 | |
| 2028 | |
| 223 | | |
| 3 | | |
| 226 | |
| 2029 | |
| 228 | | |
| – | | |
| 228 | |
| 2030 | |
| 234 | | |
| – | | |
| 234 | |
| Thereafter | |
| 1,075 | | |
| – | | |
| 1,075 | |
| | |
$ | 2,170 | | |
$ | 155 | | |
$ | 2,325 | |
| Less Interest* | |
| (676 | ) | |
| (23 | ) | |
| | |
| | |
$ | 1,494 | | |
$ | 132 | | |
| | |
Security Purchase Agreement
On March 10, 2022, the Company
issued a promissory note (“Note 1”) to Streeterville Capital, LLC with an initial principal balance of $5.4 million and a
stated interest rate of 7%. In January 2023, the Company amended Note 1 to waive the noteholder’s redemption rights through March
31, 2023 in exchange for a 3.75% fee on the outstanding principal, which was recorded as additional debt issuance costs and increased
the total indebtedness. In August 2023, the Company entered into a Forbearance Agreement, as amended, which extended the maturity date
of Note 1 to September 10, 2024 and granted Streeterville a first-priority security interest in substantially all of the Company’s
assets.
During 2024, the Company
reduced the outstanding principal of Note 1 through debt-to-equity exchanges to $0.5 million and recorded the reversal of previously recognized
interest accretion and the write-off of unamortized debt issuance costs. Although Note 1 matured on September 10, 2024, repayment was
restricted while Series A preferred stock was outstanding, which was fully redeemed on January 3, 2025. In March 2025, the Company exchanged
the remaining $0.5 million principal balance for shares of common stock, resulting in full extinguishment of Note 1. The Company recognized
approximately $8 thousand of interest expense for the three months ended March 31, 2025.
| 5. |
Commitments and Contingencies |
The Company is periodically
involved in various litigation claims asserted in the normal course of its business. The Company believes these actions are routine and
incidental to the business. While the outcome of these actions cannot be predicted with certainty, the Company does not believe that any
will have a material adverse impact on the Company’s business.
ATM Offering
On June 11, 2025, the Company
terminated its At Market Sales Agreement with B. Riley Securities, Inc. On June 12, 2025, the Company entered into a new At The Market
Offering Agreement with H.C. Wainwright & Co., LLC to potentially sell up to $50.0 million of the Company’s common stock using
a shelf registration statement on Form S-3/A (File No. 333-281565) which was filed on January 31, 2025 and became effective on February
10, 2025. During the three months ended March 31, 2026 and March 31, 2025, no sales of common stock were made under the ATM utilizing
the shelf registration.
Standby Equity Purchase Agreement
On July 3, 2024, the Company
entered into a $10
million Standby Equity Purchase Agreement (“SEPA”) with Streeterville pursuant to which the Company has the right to direct
Streeterville during the 24 month term of the agreement to purchase common stock subject to certain limitations and conditions set forth
in the SEPA. During the year ended December 31, 2024, 1.2
million shares of common stock were purchased pursuant to the SEPA resulting in aggregate net proceeds of $1.8
million of which $0.1
million was received in 2024. The remaining proceeds due were recorded as a Stock Subscription Receivable in the consolidated balance
sheet on December 31, 2024, and received in January 2025. During the three months ended March 31, 2026 and 2025, no
purchases were made pursuant to the SEPA.
Series A Preferred Stock
On March 15, 2024, the Company
filed the Amended and Restated Certificate of Incorporation (the “A&R Certificate”) to eliminate the Series 1, Series
2, and Series 3 preferred shares and filed a Certificate of Designations creating a new Series A preferred stock, $0.01 par value per
share (the “Series A preferred stock”). Pursuant to the terms of the Series A Certificate, 20 thousand shares of Series A
preferred stock are authorized, and each share of Series A preferred stock has a stated value of $1,100, accrues a rate of return on the
stated value of 10% per year, is compounded annually and is payable quarterly in cash or additional shares of Series A preferred stock.
On March 15, 2024, the Company
entered into an Exchange Agreement with Streeterville Capital that exchanged $9.3 million in debt for 9,275 shares of Series A preferred
stock.
Through the remainder of 2024,
the Company reduced the outstanding number of Series A preferred stock outstanding through redemptions and exchanges to common stock to
3,587 shares. In January 2025, the Company exchanged 3,587 shares of Series A preferred stock for 1,293 thousand shares of common stock.
All of the exchanges of Series A Preferred to common were made pursuant to the exemption from the registration requirements afforded by
Section 3(a)(9) of the Securities Act. Also in January 2025, the Company redeemed 170 shares of Series A preferred stock in conjunction
with the receipt of proceeds from the sale of common stock under the SEPA. As of March 31, 2026 and 2025, there were no remaining shares
of Series A preferred stock outstanding.
Registered Direct Offering
On January 6, 2025, the Company
sold to a single institutional investor 653 thousand shares of the Company’s common stock at a purchase price of $3.05 per share
and 1,806 thousand prefunded warrants to purchase up to 1,806 thousand shares of common stock at a purchase price of $3.0499 for aggregate
gross proceeds of $7.5 million. The prefunded warrants were exercisable immediately at an exercise price of $.0001 per share subject to
the Purchaser not being deemed a beneficial owner of greater than 4.99%. As of March 31, 2025, all the pre-funded warrants had been exercised.
Common Stock Warrants
On March 31, 2026, the Company had 3,198,085 warrants
to purchase one share of common stock at an average exercise price of $3.26 per share and average remaining term of 3.1 years.
| 7. |
Stock-Based Compensation |
The Company accounts for stock-based compensation
in accordance with ASC 718, Compensation – Stock Compensation, which requires that compensation related to all stock-based awards
be recognized in the condensed consolidated financial statements. Stock-based compensation cost is valued at fair value at the date of
grant, and the grant date fair value is recognized as expense over each award’s requisite service period with a corresponding increase
to equity or liability based on the terms of each award and the appropriate accounting treatment under ASC 718.
The Company had three stock-based compensation
plans as of March 31, 2026 and December 31, 2025. The 2023 ESPP, 2021 Omnibus Incentive Plan and the 2015 Stock Incentive
Plan. These plans provide a means through which the Company may attract and retain key personnel and to provide a means whereby directors,
officers, employees, consultants and advisors of the Company can acquire and maintain an equity interest in the Company, or be paid incentive
compensation, including incentive compensation measured by reference to the value of common stock, thereby strengthening their commitment
to the welfare of the Company and aligning their interests with those of the Company’s stockholders. These plans are discussed in
detail in the Company’s Annual Report for the year ended December 31, 2025, filed with the SEC.
The Company grants stock from the 2021 Omnibus
Incentive Plan. Grants can no longer be made from the 2015 Stock Incentive Plan.
During the three months
ended March 31, 2026 and 2025, the Company granted 29
thousand and 384 thousand restricted stock units (“RSUs”), respectively. No other grants were made during either period.
The Company recognized compensation expense of
$0.1 million, for the three months ended March 31, 2026, compared to $0.2 million for the three months ended March 31, 2025.
The Company recognizes product
revenue upon shipment or after meeting certain performance obligations. These products can include hardware, software subscriptions and
consulting services. The Company also offers software on a subscription basis subject to software as a service (“SaaS”). Warranty
costs have not been material.
The Company recognizes sales
of the Company’s datasets in accordance with FASB ASC Topic 606 whereby revenue from contracts with customers are recognized once
the criteria under the five steps below have been met:
| |
(i) |
identification of the contract with a customer; |
| |
|
|
| |
(ii) |
identification of the performance obligations in the contract; |
| |
|
|
| |
(iii) |
determination of the transaction price; |
| |
|
|
| |
(iv) |
allocation of the transaction price to the separate performance obligations; and |
| |
|
|
| |
(v) |
recognize revenue upon satisfaction of a performance obligation. |
Consulting services include
reporting and are typically done monthly, and revenue is matched accordingly.
Normal payment terms offered
to customers, distributors and resellers are net 30 days domestically. The Company does not offer payment terms that extend beyond one
year and rarely does it extend payment terms beyond its normal terms. If certain customers do not meet the Company’s credit standards,
the Company typically requires payment in advance to limit its credit exposure.
With the Company’s
newest product, INTRUSION Shield, the Company began offering software on a subscription basis. INTRUSION Shield
is a hosted arrangement subject to SaaS guidance under ASC 606. SaaS arrangements are accounted for as subscription services, not arrangements
that transfer a license of intellectual property.
The Company utilizes the
five-step process mentioned above, per FASB ASC Topic 606 to recognize sales and will follow that directive, also, to define revenue items
as individual and distinct. INTRUSION Shield services provided to its customers for a fixed monthly subscription fee include:
| |
· |
access to Intrusion’s proprietary software and database to detect and prevent unauthorized access to its clients’ information networks; |
| |
· |
use of all software, associated media, printed materials, data, files, online documentation, and any equipment that Intrusion provides for customers to access the INTRUSION Shield; and |
| |
· |
tech support, post contract customer support (PCS) includes daily program releases or corrections provided by Intrusion without additional charge. |
INTRUSION Shield
contracts provide no other services, and the Company’s customers have no rebates or return rights, nor are any such rights anticipated
to be offered as part of this service.
The Company satisfies its
performance obligation when the INTRUSION Shield solution is available to detect and prevent unauthorized access to a client’s
information networks. Revenue is recognized monthly over the term of the contract. The Company’s standard initial contract terms
automatically renew unless notice is given 30 days before renewal. Upfront payment of fees is deferred and amortized into income over
the period covered by the contract.
For the three months ended
March 31, 2026, revenues to various U.S. government entities totaled $0.8 million from three government customers, representing 87.8%
of total revenues. For the three months ended March 31, 2026, the Company’s top three customers comprised 50.8%, 36.5%, and 5.4%
of total revenues, respectively. In comparison, for the same period in 2025, revenues totaled $1.6 million from four government customers,
representing 91.6% of total revenues and the Company’s top three customers comprised 48.8%, 24.7%, and 17.9% of total revenues,
respectively.
The Company’s accounts
receivable represents unconditional contract billings for sales per contracts with customers and are classified as current assets. As
of March 31, 2026 and December 31, 2025, the Company had accounts receivable balances of $0.1 million. At March
31, 2026 and December 31, 2025, the Company had an allowance for credit losses of $0.1 million.
Contract assets are recognized
when the Company has transferred services to a customer earning the right to consideration.
Contract liabilities consist
of cash payments in advance of the Company satisfying performance obligations and recognizing revenue. The Company currently classifies
deferred revenue as a contract liability.
The following table presents
changes in the Company’s contract liabilities during the three months ended March 31, 2026, and the year ended December 31, 2025
(in thousands):
Contract Liabilities
| Schedule of contract liabilities | |
| | |
| |
| | |
March
31,
2026 | | |
December
31,
2025 | |
| Balance at beginning of period | |
$ | 503 | | |
$ | 730 | |
| Additions | |
| 1,403 | | |
| 160 | |
| Revenue recognized | |
| (862 | ) | |
| (387 | ) |
| Balance at end of period | |
$ | 1,044 | | |
$ | 503 | |
| 9. |
Capitalized Software Development |
The Company capitalizes internally
developed software using the Agile software development methodology which allows the Company to accurately track and record costs associated
with new software development and enhancements.
Pursuant to ASC Topic 350-40
Internal Use Software Accounting Capitalization, certain development costs related to the Company’s products during the application
development stage are capitalized as part of property and equipment. Costs incurred in the preliminary stages of development are expensed
as incurred. The preliminary stage includes activities such as conceptual formulation of alternatives, evaluation of alternatives, determination
of existence of needed technology, and the final selection of alternatives. Once the application development stage is reached, internal
and external costs are capitalized until the software is complete and ready for its intended use. Capitalized internal use software is
amortized on a straight-line basis over its estimated useful life, which is generally three years.
The Company reports two
separate net loss per share numbers, basic and diluted. Basic net loss attributable to common stockholders per share is computed by
dividing net loss attributable to common stockholders for the period by the weighted average number of common shares outstanding for
the period. Diluted net loss attributable to common stockholders per share is computed by dividing the net loss attributable to
common stockholders for the period by the weighted average number of common shares and dilutive common stock equivalents outstanding
for the period. The common stock equivalents include all common stock issuable upon exercise of outstanding warrants, options and
vesting of restricted stock awards. The aggregate number of common stock equivalents excluded from the diluted loss per share
calculation for the three months ended March 31, 2026, and 2025 totaled 3.6
million and 2.4
million shares, respectively. Since the Company is in a net loss position for the three months ended March 31, 2026 and 2025, basic
and dilutive net loss per share is the same.
| 11. |
Related Party Transactions |
The Company did not have any
related party transactions during the three months ended March 31, 2026 or 2025.
On April 6, 2026, the “Company entered into
a Note Purchase Agreement with Streeterville Capital, LLC, pursuant to which the Company issued a secured promissory note with an original
principal amount of $3.2 million for cash proceeds of $3.0 million, reflecting an original issue discount and transaction costs.
The note bears interest at 7% per annum, matures
24 months from issuance, and is secured by a first-priority lien on substantially all of the Company’s assets, including intellectual
property. The agreement includes customary representations, warranties, and covenants, and the note provides for certain redemption rights
beginning six months after issuance.
On May 7, 2026, the Company
received a written notice (the “Bid Price Notice”) from the Nasdaq Stock Market LLC (“NASDAQ”) notifying the Company
that it is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum
Bid Price Requirement”) for continued listing on the NASDAQ Capital Market. The notification of noncompliance has no immediate
effect on the listing or trading of the Company’s common stock on The NASDAQ Capital Market under the symbol “INTZ,”
and the Company is currently monitoring the closing bid price of its common stock and evaluating its alternatives, if appropriate, to
resolve the deficiency and regain compliance with this rule.
On May 13, 2026, the Company
entered into a subcontractor agreement to provide cybersecurity and critical infrastructure protection support services for a state government
agency. The agreement has an initial one year term beginning in May 2026 and represents aggregate contract value of approximately
$3.9 million. Revenue related to this arrangement will be recognized over time as performance obligations are satisfied in according
with ASC 606, Revenue from Contracts with Customers. No revenue related to the agreement was recognized during the three
months ended March 31, 2026.
Item 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Forward-Looking Statements
This Quarterly Report on Form
10-Q, including, without limitation, the section entitled “Management’s Discussion and Analysis of Financial Condition and
Results of Operations,” contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
which statements involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this
Quarterly Report on Form 10-Q, including statements regarding our financial position; our ability to continue our business as a going
concern; our business, sales, and marketing strategies and plans; our ability to successfully market, sell, and deliver our INTRUSION
Shield commercial product and solutions to an expanding customer base; and our ability to secure additional financing; are
forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,”
“believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,”
“intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,”
“target,” “will,” or “would” or the negative of these words or other similar terms or expressions.
Forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to, such statements.
You should not rely on forward-looking
statements as predictions of future events. We have based the forward-looking statements contained in this Quarterly Report on Form 10-Q
primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial
condition, and operating results. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties,
and other factors described in the section titled “Risk Factors” in this Quarterly Report on Form 10-Q and our most recent
Annual Report on Form 10-K, as the same may be amended or updated from time to time.
In addition, statements such
as “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based
on information available to us as of the date of this Quarterly Report on Form 10-Q. While we believe that such information provides a
reasonable basis for these statements, that information may be limited or incomplete. Our statements do not indicate that we have conducted
an exhaustive inquiry into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned
not to unduly rely on these statements.
The forward-looking statements
made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation
to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date
of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law.
Overview
We offer businesses of all
sizes and industries products and services that leverage our exclusive threat intelligence database of over 8.5 billion IP addresses and
domain names. After many years of gathering intelligence and providing our INTRUSION TraceCop and Savant solutions
exclusively to government entities, we released our first commercial product in 2021, the INTRUSION Shield. INTRUSION
Shield was designed to allow businesses to incorporate a Zero Trust, reputation-based security solution into their existing
infrastructure to observe traffic flow and instantly block known malicious or unknown connections from both entering or exiting a network,
making it an ideal solution for protecting from Zero-Day and ransomware attacks.
Results of Operations
Comparison of the Periods Ended March 31, 2026, and March 31, 2025
| | |
Three Months Ended March 31, | | |
Change | |
| (in thousands) | |
2026 | | |
2025 | | |
Dollar | | |
Percentage | |
| Revenue | |
$ | 888 | | |
$ | 1,775 | | |
$ | (887 | ) | |
| -50.0% | |
| Cost of Revenue | |
| 229 | | |
| 432 | | |
| (203 | ) | |
| -47.0% | |
| | |
| | | |
| | | |
| | | |
| | |
| Gross Profit | |
| 659 | | |
| 1,343 | | |
| (684 | ) | |
| -50.9% | |
| | |
| | | |
| | | |
| | | |
| | |
| Operating Expenses: | |
| | | |
| | | |
| | | |
| | |
| Sales and marketing | |
| 1,631 | | |
| 1,184 | | |
| 447 | | |
| 37.8% | |
| Research and development | |
| 1,451 | | |
| 1,218 | | |
| 233 | | |
| 19.1% | |
| General and administrative | |
| 1,149 | | |
| 1,034 | | |
| 115 | | |
| 11.1% | |
| | |
| | | |
| | | |
| | | |
| | |
| Operating Loss | |
| (3,572 | ) | |
| (2,093 | ) | |
| (1,479 | ) | |
| -70.7% | |
| | |
| | | |
| | | |
| | | |
| | |
| Interest Expense | |
| (11 | ) | |
| (29 | ) | |
| 18 | | |
| -62.1% | |
| Other Income (Expense), Net | |
| 20 | | |
| 24 | | |
| (4 | ) | |
| -16.7% | |
| | |
| | | |
| | | |
| | | |
| | |
| Net Loss | |
$ | (3,563 | ) | |
$ | (2,098 | ) | |
$ | (1,465 | ) | |
| -69.8% | |
Revenues.
Revenue for the three month period ended March 31, 2026, was $0.9 million compared to $1.8 million for the same period in 2025.
Revenue from consulting services totaled $0.8 million for the three month period ended March 31, 2026, compared to $1.4 million for
the three month period ended March 31, 2025. INTRUSION Shield revenues were $0.1 million for the three month period
ended March 31, 2026 as compared to $0.4 million for the three month period ended March 31, 2025. The continuing delay in the
contract extension of the long-standing U.S. Department of War contract due to timing variability and federal funding and
procurement processes resulted in a decline in both consulting revenues and INTRUSION Shield revenues.
Concentration of Revenues.
Revenues from sales to various U.S. government entities totaled $0.8 million, or 87.8% of revenues, for the quarter ended March 31,
2026, compared to $1.6 million, or 91.6% of revenues, for the same period in 2025. Although we expect our concentration of revenues to
vary among customers in future periods depending upon the timing of certain sales, we anticipate that sales to government customers will
continue to account for a significant portion of our revenues in future periods. Sales to the government present risks in addition to
those involved in sales to commercial customers which could adversely affect our revenues, including, without limitation, potential disruption
to appropriation and spending patterns and the government’s reservation of the right to cancel contracts and purchase orders for
its convenience. Although we do not anticipate contracts with government customers will be renegotiated or cancelled, the loss of government
orders could have a material adverse effect on our financial results. We had two customers accounting for 87.3% of total revenue for the
three months ended March 31, 2026. We had three customers in the first quarter of 2025 that accounted for 91.4% of total revenue. Our
similar product and service offerings are not viewed as individual segments, as our management analyzes the business as a whole and expenses
are not allocated to each product offering.
Gross Profit. Gross
profit was $0.7 million, or 74.2%, of revenues for the quarter ended March 31, 2026, compared to $1.3 million, or 75.7%, of revenues for
the quarter ended March 31, 2025. The decrease in gross profit margin for the 2026 period is a result of a change in product mix with
INTRUSION Shield revenues representing only 12.7% of our revenue mix compared to 23.4% in the same period in 2025.
Operating Expenses. Operating
expenses for the quarter ended March 31, 2026, totaled $4.2 million, a $0.8 million increase compared to the same period in 2025. The
increase is primarily related to increased investment in sales and R&D personnel as we continue to expand our product offerings and
brand awareness, further impacted by cost of living and merit increases that occurred in the second half of 2025. The increase is also
due to a decrease in the allocations out of operating expense to cost of sales due to the underutilization of resources to support the
delayed U.S. Department of War contract.
Sales and Marketing. Sales
and marketing expenses totaled $1.6 million for the quarter ended March 31, 2026, representing an increase of $0.4 million compared to
the same period in 2025. The increase was primarily due to an increased investment in sales and sales support personnel and an increased
participation in trade shows and associated marketing spend to continue to create more brand awareness and growth in our pipeline as well
as an underutilization of our government sales team due to the delayed U.S. Department of War contract. Certain discretionary marketing
spends inclusive of participation in trade shows, utilization of third-party contractors for content and product messaging and travel,
are likely to vary over time based on marketing and savings initiatives that may be necessary.
Research and Development.
Research and development expenses totaled $1.5 million for the quarter ended March 31, 2026, representing an increase of $0.2 million
compared to the same period in 2025. The increase is primarily due to a $0.3 million decrease in internally developed software as we continue
to invest in adding new features and functionality to INTRUSION Shield, partially offset by a $0.1 million decrease in amortization
expense associated with the termination of one of our material finance leases at the end 2025. Research and development costs may vary
over time as we determine the frequency of new releases, improved functionality and enhancements needed to be competitive with our product
offering.
General and Administrative.
General and administrative expenses totaled $1.1 million for the quarter ended March 31, 2026, compared to $1.0 million for the quarter
ended March 31, 2025. The increase is primarily due to an increase in operating lease expenses associated with the Plano office space.
Interest Expense. Interest
expense for the three months ended March 31, 2026, was $11 thousand, consisting principally of imputed interest on finance leases. Interest
expense for the 2025 period totaled $29 thousand and consisted principally of the stated interest related to the Streeterville note and
imputed interest on finance leases.
Other Income (Expense),
Net. Other income and expense were nominal amounts for both the periods ended March 31, 2026, and 2025.
Net Loss. Net loss
for the first quarter of 2026 was $3.6 million, or $0.18 per share, compared to a net loss of $2.1 million, or $0.11 per share, for the
first quarter of 2025. The increase in net loss for 2026 was primarily a result of the decrease in revenues for the 2026 period as discussed
above.
Liquidity and Capital Resources
Sources of Liquidity
As of March 31, 2026, we
had cash and cash equivalents of $1.4 million. Net working capital at March 31, 2026 totaled ($0.9) million compared to $2.4 million as
of December 31, 2025. Our principal sources of cash for funding operations in the March 2026 and March 2025 quarters were receipt of proceeds
from the sale of common stock pursuant to the SEPA $1.5 million, recorded as stock subscription receivable at December 31, 2024, and net
proceeds of $7.0 million from a registered direct offering that closed on January 6, 2025. On April 6, 2026, we received $3.0 million
in cash related to the sale of a promissory note with Streeterville Capital, LLC.
We generated a net loss of
$3.6 million and $2.1 million for the three months ended March 31, 2026, and 2025, respectively. If our operations do not generate positive
cash flow in the upcoming year, of if we are not able to obtain additional debt or equity financing on terms and conditions acceptable
to us, we may be unable to implement our business plan, fund our liquidity needs or even continue our operations.
ATM Program
On June 11, 2025, we terminated
our At Market Sales Agreement with B. Riley Securities, Inc. The following day, on June 12, 2025, we entered into a new At The Market
Offering Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC to potentially sell up to $50.0 million of
the Company’s common stock using a shelf registration statement on Form S-3/A (File No. 333-281565) which was filed on January 31,
2025 and became effective on February 10, 2025. No sales under the new shelf registration have been made to date.
Notes Payable
In March 2025, through three
separate exchange agreements we retired the remaining $0.5 million in Streeterville debt through the issuance of 552.3 thousand shares
of common stock. The issuance of common stock was made pursuant to the exemption from the registration requirements afforded by the Securities
Act.
Unaudited Condensed Consolidated Statements of Cash Flows
Our cash flows for the three months ended March
31, 2026 and 2025 were:
| | |
Three Months Ended March 31, | |
| | |
2026 | | |
2025 | |
| Net cash used in operating activities | |
$ | (1,821 | ) | |
$ | (1,690 | ) |
| Net cash used in investing activities | |
| (252 | ) | |
| (787 | ) |
| Net cash (used in) provided by financing
activities | |
| (185 | ) | |
| 8,370 | |
| Change in cash and cash equivalents | |
$ | (2,258 | ) | |
$ | 5,893 | |
Operating Activities
Net cash used in operations
for the quarter ended March 31, 2026, was $(1.8) million due primarily to a net loss of $(3.6) million partially offset by 1) adjustments
for non-cash items of $0.7 million which are mostly comprised of depreciation and stock-based compensation, and 2) changes in working
capital of $1.1 million.
Net cash used in operations
for the quarter ended March 31, 2025, was $(1.7) million principally due to a net loss of $(2.1) million partially offset by 1) adjustments
for non-cash items of $0.8 million which are mostly comprised of depreciation and stock-based compensation, and 2) changes in working
capital of $(0.4) million.
Investing Activities
For the three months ended
March 31, 2026, net cash used in investing activities was $(0.3) million, which was comprised of capitalization of internally developed
software and hardware purchases. Net cash used by investing activities for the three months ended March 31, 2025, was $(0.8) million,
which was principally comprised of capitalization of internally developed software and purchases of property and equipment.
Financing Activities
For three months ended March
31, 2026, net cash used in financing activities was $0.2 million which was principally comprised of cash paid on tax withholding for net
settled restricted stock units. Net cash provided by financing activities for the three months ended March 31, 2025, was $8.4 million
which resulted from the receipt of proceeds from the sale of common stock pursuant to the SEPA of $1.5 million, previously recorded as
stock subscription receivable at December 31, 2024, and net proceeds of $7.0 million from a registered direct offering that closed on
January 6, 2025.
Critical Accounting Policies and Use of Estimates
Our unaudited condensed consolidated
financial statements have been prepared in accordance with U.S. GAAP. The preparation of these unaudited condensed consolidated financial
statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and
related disclosures. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under
the circumstances. We evaluate our estimates and assumptions on an ongoing basis. Actual results may differ from these estimates. To the
extent that there are material differences between these estimates and our actual results, our future financial statements will be affected.
We believe the critical accounting
policies and estimates discussed under “Management’s Discussion and Analysis of Financial Condition and Results of Operations”
included in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 25, 2026 (the “2025
Annual Report”) reflect our more significant judgments and estimates used in the preparation of the condensed consolidated financial
statements. There have been no significant changes to our critical accounting policies and estimates as disclosed in the 2025 Annual Report.
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES
ABOUT MARKET RISK
Not applicable.
Item 4. CONTROLS AND PROCEDURES
Evaluation of Effectiveness of Disclosure Controls
and Procedures
We maintain “disclosure
controls and procedures,” as defined in Rule 13a-15(e) under the Exchange Act, that are designed to ensure that information required
to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time
periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including
our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no
matter how well conceived and operated, can provide only reasonable assurance of achieving the desired control objectives, and we must
apply our reasonable judgment in evaluating the cost-benefit relationship of potential disclosure controls and procedures.
As of March 31, 2026, our
management, including our principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation
of our disclosure controls and procedures and concluded that the disclosure controls and procedures were effective as of March 31, 2026.
Changes in Internal Control over Financial Reporting
There have not been any changes
in our internal control over financial reporting that occurred during the three months ended March 31, 2026, that have materially affected,
or are reasonably likely to materially affect, our internal control over financial reporting.
PART II – OTHER INFORMATION
Item 1. LEGAL PROCEEDINGS
As of March 31, 2026, the
Company is not involved in any material pending legal proceedings. The Company is periodically involved in various litigation claims asserted
in the normal course of its business. The Company believes these actions are routine and incidental to the business. While the outcome
of these actions cannot be predicted with certainty, the Company does not believe that any will have a material adverse impact on the
Company’s business.
Item 1A. RISK FACTORS
As a smaller reporting company,
we are not required to disclose material changes to the risk factors that were contained in the 2025 Annual Report. You should carefully
consider the risk factors we previously disclosed in the 2025 Annual Report. These risks could materially and adversely affect our business,
financial condition, results of operations, and cash flows. However, these risks are not the only risks we face. Additional risks and
uncertainties not presently known to us or that we currently deem immaterial also may impair our business, financial condition, results
of operations, and cash flows.
Item 2. UNREGISTERED SALES OF EQUITY SECURITIES
USE OF PROCEEDS AND ISSUER PURCHASES OF EQUITY SECURITIES
Not applicable.
Item 3. DEFAULTS UPON SENIOR SECURITIES
Not applicable.
Item 4. MINE SAFETY DISCLOSURES
Not applicable.
Item 5. OTHER INFORMATION
| |
(b) |
There have been no material changes to procedures by which security holders may recommend nominees to the Company’s Board of Directors since the Company last provided disclosure in response to the requirements of Item 407(c)(3) of Regulation S-K. |
| |
(c) |
During the three months ended March 31, 2026, no director or officer adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408(a) of Regulation S-K. |
Item 6. EXHIBITS
The following Exhibits are filed or furnished with this Quarterly report
on Form 10-Q:
| Exhibit No. |
Description |
| 10.1 |
Note Purchase Agreement, dated as of April 6, 2026, by and between the registrant and Streeterville Capital, LLC (incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form
8-K filed on April 9, 2026). |
| 31.1* |
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Exchange Act. |
| 31.2* |
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Exchange Act. |
| 32.1** |
Certification Pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 101.INS* |
XBRL Instance Document |
| 101.SCH* |
XBRL Taxonomy Extension Schema Document |
| 101.CAL* |
XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.LAB* |
XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE* |
XBRL Taxonomy Extension Presentation Linkbase Document |
| 101.DEF* |
XBRL Taxonomy Extension Definition Linkbase Document |
| 104* |
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
*Filed herewith
**Furnished herewith.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
| |
|
INTRUSION INC. |
|
| |
|
|
| Date: May 14, 2026 |
|
/s/ Anthony Scott |
|
|
| |
|
Anthony Scott |
|
| |
|
President & Chief Executive Officer |
|
| |
|
(Principal Executive Officer) |
|
| |
|
|
| |
|
|
| Date: May 14, 2026 |
|
/s/ Kimberly Pinson |
|
|
| |
|
Kimberly Pinson |
|
| |
|
Chief Financial Officer |
|
| |
|
(Principal Financial & Accounting Officer) |
|